Martin Madaus

Martin Madaus

Presidente presso REPLIGEN CORPORATION

Patrimonio netto: 2 M $ in data 30/06/2026

66 anni
Health Technology
Commercial Services
Health Services

Profilo

Martin D.
Madaus
is Chairman at Repligen Corp.
starting 2026.
Executive Chairman at Emulate, Inc. since 2020.
Director at Candela Corp., Massachusetts High Technology Council, Inc., Ultivue, Inc., Syntis Bio, Inc., and Candela Medical, Inc. since 2018.
Independent Director at Azenta, Inc. starting 2024.
Director at Unchained Labs LLC since 2021.
Director at Haemonetics Corp.
starting 2026.
Senior Operating Executive at The Carlyle Group Inc. since 2019.
Formerly Chairman, President & Chief Executive Officer at EMD Millipore Corp.
from 2010.
Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010.
Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019.
President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004.
Independent Director at Mettler-Toledo International, Inc. from 2011 to 2015.
Independent Director at Covidien Unlimited Co. from 2011 to 2014.
Independent Director at Standard BioTools, Inc. from 2022 to 2024.
Independent Director at Hologic, Inc. from 2024 to 2026.
Director at Quanterix Corp.
from 2010 to 2025.
Chief Operations Officer at Sherlock Biosciences, Inc. from 2020 to 2021.
Vice President-Business Development at Roche Molecular Systems, Inc. Education includes doctorates from Ludwig-Maximilians-Universität München in 1985 and The University of Veterinary Medicine Hanover.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
14/05/2026 8.392 ( 0,01% ) 1 M $ 30/06/2026
24/07/2026 2.538 ( 0,01% ) 190 350 $ 30/06/2026
05/02/2026 7.405 ( 0,02% ) 188 976 $ 30/06/2026

Posizioni attive di Martin Madaus

SocietàPosizioneInizio
CANDELA MEDICAL, INC. Direttore/Membro del Consiglio 01/05/2018
REPLIGEN CORPORATION Presidente 13/03/2026
AZENTA, INC. Direttore/Membro del Consiglio 30/01/2024
HAEMONETICS CORPORATION Direttore/Membro del Consiglio 24/07/2026
THE CARLYLE GROUP INC. Corporate Officer/Principal 01/01/2019
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/07/2021
Direttore/Membro del Consiglio -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Precedenti posizioni note di Martin Madaus

SocietàPosizioneFine
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Martin Madaus

Formazione di Martin Madaus

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

69

Relazioni di 1° grado

31

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private31

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Finance

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Martin Madaus